Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63,144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer.
Zhang K, Liu K, Hu B, Du G, Chen X, Xiao L, Zhang Y, Jiang L, Jing N, Cheng C, Wang J, Xu P, Wang Y, Ma P, Zhuang G, Zhao H, Sun Y, Wang D, Wang Q, Xue W, Gao WQ, Zhang P, Zhu HH. Zhang K, et al. Among authors: wang j, wang y, wang d, wang q. Nat Commun. 2024 Oct 20;15(1):9050. doi: 10.1038/s41467-024-53233-1. Nat Commun. 2024. PMID: 39426954 Free PMC article.
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer.
Cheng C, Wang J, Xu P, Zhang K, Xin Z, Zhao H, Ji Z, Zhang M, Wang D, He Y, Jing N, Fan L, Liu K, Li F, Liu C, Gong Y, Cui S, Sun Z, Sun D, Yao X, Li H, Zhang J, Zhang P, Dong B, Xue W, Qian X, Gao WQ, Zhu HH. Cheng C, et al. Among authors: wang j, wang d. Nat Cancer. 2022 May;3(5):565-580. doi: 10.1038/s43018-022-00380-3. Epub 2022 May 27. Nat Cancer. 2022. PMID: 35624341
IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer.
Wang D, Cheng C, Chen X, Wang J, Liu K, Jing N, Xu P, Xi X, Sun Y, Ji Z, Zhao H, He Y, Zhang K, Du X, Dong B, Fang Y, Zhang P, Qian X, Xue W, Gao WQ, Zhu HH. Wang D, et al. Among authors: wang j. Adv Sci (Weinh). 2023 Jun;10(17):e2206889. doi: 10.1002/advs.202206889. Epub 2023 Apr 24. Adv Sci (Weinh). 2023. PMID: 37092583 Free PMC article.
ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.
Jing N, Zhang K, Chen X, Liu K, Wang J, Xiao L, Zhang W, Ma P, Xu P, Cheng C, Wang D, Zhao H, He Y, Ji Z, Xin Z, Sun Y, Zhang Y, Bao W, Gong Y, Fan L, Ji Y, Zhuang G, Wang Q, Dong B, Zhang P, Xue W, Gao WQ, Zhu HH. Jing N, et al. Among authors: wang j, wang d, wang q. J Clin Invest. 2023 Dec 15;133(24):e168670. doi: 10.1172/JCI168670. J Clin Invest. 2023. PMID: 38099497 Free PMC article.
Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer.
Wang D, Du G, Chen X, Wang J, Liu K, Zhao H, Cheng C, He Y, Jing N, Xu P, Bao W, Xi X, Zhang Y, Wang N, Liu Y, Sun Y, Zhang K, Zhang P, Gao WQ, Zhu HH. Wang D, et al. Among authors: wang j, wang n. Cell Death Differ. 2024 Jun;31(6):779-791. doi: 10.1038/s41418-024-01295-5. Epub 2024 Apr 23. Cell Death Differ. 2024. PMID: 38654072
Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation.
He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X, Miao J, Zhang K, Zhang W, Ma P, Zhao H, Cheng C, Wang D, Wang J, Jing N, Liu K, Zhang P, Dong B, Zhuang G, Fu Y, Xue W, Gao WQ, Zhu HH. He Y, et al. Among authors: wang j, wang d. Cell Rep. 2023 Feb 28;42(2):112033. doi: 10.1016/j.celrep.2023.112033. Epub 2023 Jan 31. Cell Rep. 2023. PMID: 36724072 Free article.
63,144 results
You have reached the last available page of results. Please see the User Guide for more information.